来那度胺胶囊 (Manufacturer:Celgene) |进行中-招募完成

登记号
CTR20132976
相关登记号
CTR20132221
曾用名
药物类型
化学药物
临床申请受理号
企业选择不公示
适应症
多发性骨髓瘤
试验通俗题目
评价来那度胺一线治疗多发性骨髓瘤的有效性和安全性
试验专业题目
评价来那度胺联合低剂量地塞米松一线治疗多发性骨髓瘤的疗效及安全性的随机开放3个治疗组的Ⅲ期研究
试验方案编号
CC-5013-MM-020 方案修订版4(终稿2012年3月25日)
方案最近版本号
版本日期
方案是否为联合用药
企业选择不公示

申请人信息

申请人名称
联系人姓名
林侠
联系人座机
021-61339235
联系人手机号
联系人Email
hlin@celgene.com
联系人邮政地址
上海市黄浦区南昌路45号城汇大厦21楼
联系人邮编
200020

临床试验信息

试验分类
安全性和有效性
试验分期
III期
试验目的
来那度胺与低剂量地塞米松联合疗法与美法仑、泼尼松、沙利度胺联合疗法在一线治疗多发性骨髓瘤的安全性及有效性对比
随机化
随机化
盲法
开放
试验范围
国际多中心试验
设计类型
平行分组
年龄
18岁(最小年龄)至 NA岁(最大年龄)
性别
男+女
健康受试者
入选标准
  • 1 必须知晓并自愿签署知情同意书
  • 2 签署知情同意书时年龄大于等于18 岁
  • 3 未经过既往治疗的MM症候,按以下3 个标准定义:
  • 3.1 MM 诊断标准(符合所有 3 项)*1:3.1.1 骨髓中单克隆浆细胞 大于等于10% 和/或存在经活检证实的浆细胞瘤; 3.1.2 血清和/或尿中存在单克隆蛋白; 3.1.3 多发性骨髓瘤相关器官功能障碍(至少下列之一):[C] 血钙升高(血钙大于10.5 mg每dl 或至正常上限)[R] 肾功能不全(血清肌酐大于2 mg每dl)[A] 贫血(血红蛋白小于10 g每dl 或低于实验室正常值 2 g)[B] 溶骨性病灶或骨质疏松症 *1 许多其他类型的终末器官功能障碍会偶尔发生并且需要治疗。这样的功能障碍如果证明与骨髓瘤有关,可用于界定为骨髓瘤。
  • 3.2 同时存在蛋白电泳分析确认的疾病,定义如下:3.2.1 IgG 多发性骨髓瘤:血清单克隆异常蛋白(M 蛋白)水平大于等于1.0 g每dl 或尿 M 蛋白水平大于等于200 mg每24 h 3.2.2 IgA 多发性骨髓瘤:血清 M 蛋白水平大于等于 0.5 g/dl 或尿 M 蛋白水平大于等于200 mg/24 h 3.2.3 IgM 多发性骨髓瘤(IgM M 蛋白+骨骼检查平片报告的溶骨性骨骼疾病):血清M蛋白水平大于等于1.0 g每dL或尿M蛋白水平大于等于200 mg每24 h 3.2.4 IgD 多发性骨髓瘤:血清M蛋白水平大于等于0.05 g每dl 或尿M蛋白水平大于等于200 mg每24 h 3.2.5 轻链型多发性骨髓瘤:血清M蛋白水平大于等于1.0 g/dl 或尿M蛋白水平大于等于200 mg每24 h
  • 3.3 同时65 岁或以上,或者如果年龄小于 65岁,则是因为下列原因而不适合干细胞移植的患者:拒绝接受干细胞移植或由于费用或其他原因不能接受干细胞移植的患者
  • 4. ECOG 体能状态为 0、1、或 2
  • 5. 能遵守就诊时间和试验方案中要求
  • 6. 可能受孕女性 (FCBP)*2 必须:6.1 必须同意在开始Rd 或MPT 治疗研究前进行2 次医学监督下的妊娠检测。首次妊娠检测在Rd 或MPT 治疗开始前的10-14天内进行,第二次妊娠检测在Rd 或MPT 治疗开始前24 小时之内进行。她必须同意在研究期间和研究治疗结束后进行妊娠检测。此规定同样适用于进行完全且持续性禁欲的患者。6.2 必须同意在服用研究药物开始前28 天,研究治疗期间(包括用药暂停期间),及终止研究治疗后的28 天内坚持避免异性性交(必须按每个月审查),或者持续采用有效的避孕措施。*2 FCBP 是指性成熟妇女:1)未曾进行子宫切除术或双侧卵巢切除术,或2)无至少连续24 个月(即在之前连续24 个月内的任何时间出现月经)自然地停经(癌症治疗后的闭经不能排除分娩可能)。
  • 7. 男性患者必须:在整个研究药物治疗期,任何用药暂停期、和研究治疗停止后,即使已经进行了输精管切除术,必须同意在与FCBP 进行性交期间使用避孕套。必须同意在研究药物治疗期间和研究药物治疗结束后的一段时间不捐赠精液和精子。
  • 8. 所有患者必须:了解研究药物可能有潜在的致畸危险。同意服用研究药物治疗期间和研究药物治疗停止后不捐献血液。同意不与他人分享研究药物。必须告诫所有FCBP和男性患者警惕妊娠及胎儿暴露于研究药物的风险。
排除标准
  • 曾经接受过抗骨髓瘤治疗(不包括放射放疗、双磷酸盐或单次短期激素治疗 [即小于或相当于地塞米松40mg每天,4 天的剂量;在入组14 天内不能进行这样的短期治疗])。
  • 任何会使参加本研究的患者遭受不可接受风险的严重疾病。此类医学状况包括但不限于不稳定性心脏病患者,定义为:过去6 个月内发生过诸如MI这样的心脏事件、NHYA Ⅲ-Ⅳ级心力衰竭、 未得到控制的心房颤动或高血压;其状况需要长期类固醇或免疫抑制剂治疗,除研究治疗之外可能还需要类固醇或免疫抑制剂治疗的患者,例如风湿性关节炎、多发性硬化和狼疮患者。
  • 妊娠或哺乳期女性。
  • 以下任何一项实验室检测异常:嗜中性粒细胞绝对计数(ANC)小于1,000每mL(1.0 乘 10的9次方每L);未经输血的血小板计数小于50,000 细胞每mL(50 乘 10的9次方每L);血清SGOT或AST 或SGPT每ALT 大于正常值上限(ULN)的3.0 倍
  • 需要血液透析或腹膜透析的肾衰。
  • 除多发性骨髓瘤之外的恶性肿瘤病史,除非患者疾病治愈期大于等于3年。以下肿瘤疾病除外:皮肤基底细胞癌,鳞状上皮细胞癌,宫颈原位癌,乳腺原位癌,前列腺癌偶然组织学发现(TNM T1a 或T1b 期)
  • 不能或不愿进行抗血栓治疗的患者
  • 大于等于2 级的周围神经病变
  • 已知HIV阳性,或甲肝、乙型肝炎或丙型肝炎感染期活动期患者,或乙型肝炎表面抗原(HBsAG)呈阳性的乙型肝炎慢性携带者,或聚合酶链反应(PCR)显示乙型肝炎病毒脱氧核糖核酸(HBV DNA)水平可测。
  • 原发性AL(免疫球蛋白轻链)型淀粉样变性及骨髓瘤并发淀粉样变性。

试验分组

试验药
名称 用法
中文通用名:来那度胺胶囊 (Manufacturer:Celgene)
用法用量:胶囊;规格:2.5mg, 5mg, 10mg, 15mg, 20mg, 25 mg;口服,第1-21天每天一次或隔天一次,每次2.5mg 或5mg或10mg或15mg或20mg或25mg,28天为一周期,直至疾病进展
中文通用名:地塞米松片(Manufacturer:Roxane Laboratories)
用法用量:片剂;规格4 mg,口服,第1,8,15和22天给药,每天一次,每次20mg 或40mg, 28天为一周期,直至疾病进展
中文通用名:来那度胺胶囊 (Manufacturer:Celgene)
用法用量:胶囊;规格:2.5mg,5mg, 10mg, 15mg 20mg, 25 mg ;口服,第1-21天每天一次或隔天一次,每次2.5mg或5mg或10mg或15mg或20mg 或25mg,28天为一周期,给药18周期
中文通用名:地塞米松片 (Manufacturer:Roxane Laboratories)
用法用量:片剂; 规格4mg, 口服, 第1,8,15和22天给药,每天一次,每次20mg或40mg,28天为一周期,给药18周期
中文通用名:地塞米松片(Manufacturer:Ratiopharm , Merckle GmbH)
用法用量:片剂;规格4 mg,口服,第1,8,15和22天给药,每天一次,每次20mg 或40mg, 28天为一周期,直至疾病进展
中文通用名:地塞米松片(Manufacturer:Ratiopharm , Merckle GmbH)
用法用量:片剂; 规格4mg, 口服, 第1,8,15和22天给药,每天一次,每次20mg或40mg,28天为一周期,给药18周期
对照药
名称 用法
中文通用名:美法仑片 (Manufacturer: GSK 或Excella GmbH)
用法用量:片剂;规格2mg;口服,第1-4天给药,每天一次,每次0.25mg/kg 或0.125 mg/kg 或0.20mg/kg或 0.10mg/kg,42天为一周期,给药12周期
中文通用名:醋酸泼尼松片( Manufacturer:Roxane Laboratories)
用法用量:片剂;规格:5mg,10mg, 20mg ,50mg;口服,第1-4天给药,每天一次,每次 2mg/kg,42天为一周期,给药12周期
中文通用名:沙利度胺片( Manufacturer:Celgene )
用法用量:胶囊;规格:50mg, 100mg, 200mg;口服,第1-42天给药,每天一次,每次100mg或200mg, 42天为一周期,给药12周期

终点指标

主要终点指标
指标 评价时间 终点指标选择
无进展生存期(PFS) 直至436周 有效性指标
次要终点指标
指标 评价时间 终点指标选择
总生存期(OS) 直至436周 有效性指标
缓解率(完全缓解[CR]、非常好的部分缓解(VGPR), 部分缓解[PR]、和总缓解[CR +VGPR +PR]) 第二周期第一天到研究终止; 直至430周 有效性指标
反应时期 第二周期第一天到研究终止; 直至430周 有效性指标
反应时间 直至436周 有效性指标
安全性 直至436周并且研究最后一名受试者服用最后一剂药物的28天内 安全性指标
治疗失败时间(TTF) 直至436周 有效性指标
至开始二线抗骨髓瘤治疗的时间 直至436周 有效性指标
二线抗骨髓瘤治疗取得的最好反应 直至436周 有效性指标
恶性骨髓瘤克隆基线细胞遗传学结果与临床疗效的关系 直至436周 有效性指标
生活质量 (QOL) 直至436周 有效性指标
药物经济学/临床效益 直至436周 有效性指标
数据安全监察委员会(DMC)
为受试者购买试验伤害保险

研究者信息

姓名 学位 职称 电话 Email 邮政地址 邮编 单位名称
Thierry FACON 教授 +333.20.44.57.12 thierry.facon@chru-lille.fr Rue Michel Polonovski, Road number 1, Lille, France 59037 Centre Hospitalier Regional Universitaire Hopital Claude Huriez Service des Maladies du Sang

各参加机构信息

机构名称 (主要)研究者 国家 地区 城市
Centre Hospitalier Regional Universitaire Hopital Claude Huriez Service des Maladies du Sang Thierry FACON 法国 Lille
北京大学人民医院 路瑾 中国 北京 北京
中国医学科学院北京协和医学院血液病医院(血液学研究所) 邱录贵 中国 天津 天津
北京朝阳医院 陈文明 中国 北京 北京
四川大学华西医院 刘霆 中国 四川 成都
上海交通大学医学院附属瑞金医院 沈志祥 中国 上海 上海
Gosford Hospital Cecily Forsyth Australia NSW Gosford
Wollongong Hospital Peter Presgrave Australia NSW Wollongong
The Royal Melbourne Hospital Jeff Szer Australia VIC Parkville
Royal Brisbane and Women’s Hospital Simon Durrant Australia QLD Herston
Geelong Hospital Philip Campbell Australia VIC Geelong
Princess Alexandra Hospital Peter Mollee Australia QLD Woolloongabba
Flinders Medical Centre Douglas Coghlan Australia SA Bedford Park
Gold Coast Hospital Jeremy Wellwood Australia QLD Southport
Royal Perth Hospital Paul Canniff Australia WA Perth
Cabrini Hospital Henry Miles Prince Australia WA Malvern
Border Medical Oncology Richard Eek Australia VIC Wodonga
Frankston Hospital John Catalano Australia Frankston Frankston
Royal Adelaide Hospital Noemi Horvath Australia SA Adelaide
Hospital Wels Josef Thaler Austria Wels
Hospital of Barmherzige Schwestern Linz Andreas Petzer Austria Linz
Hospital of Elisabethinen Linz Hedwig Kasparu Austria Linz
Peter MacCallum Cancer Centre Divsion of Haematology/Medical Oncology Simon Harrison Australia VIC E. Melbourne
Hospital Leoben Angelika Pichler Austria Leoben
Western Hospital William Renwick Australia VIC Footscray
Hospital of the Barmherzigen Brüder Vienna Johannes Meran Austria Vienna
General Hospital Linz Michael Fridrik Austria Linz
Hospital St. Polten Peter Balcke Austria St. Polten
Hospital Wiener Neustadt Gerhard Weidinger Austria Wiener Neustadt
Westmead Hospital Amanda Johnston Australia NSW Wentworthville
MM-015.Wihelminenspital Heinz Ludwig Austria Vienna
MM-015. Medizinische Universit?t Wien Heinz Gisslinger Austria Vienna
MM-015. Salzburger Landkliniken, St. Johanns-Spital, Universit?tsklinik fur Innere Medizin III Richard Greil Austria Salzburg
Cliniques Universitaires UCL de Mont-Godine Chantal Doyen Belgium Yvoir
Jules Bordet Institut Nathalie Meuleman Belgium Brussel
Les Cliniques du Sud Luxembourg Pascal Pierre Belgium Arlon
Cliniques Universitaires St-Luc Marie-Christiane Vekemans Belgium Bruxelles
Hopital Erasme Walter Feremans Belgium Brussels
H. Hartziekenhuis Roeselare-Menen vzw campus Wilgenstraat Hilde Demuynck Belgium Roeselare
Royal North Shore Hospital Naomi MacKinlay Australia NSW St Leonards
ZNA Stuivenberg Centrumziekenhuis Ka Lung Wu Belgium Antwerpen
AZ Sint-Jan AV Brugge Jan Van Droogenbroeck Belgium Brugge
AZ-VUB Rik Schots Belgium Brussels
Universitair Ziekenhuis Leuven, Campus Gasthuisberg Michel Delforge Belgium Leuven
Universitair Ziekenhuis Gent Fritz Offner Belgium Gent
Virga Jesse Ziekenhuis Greet Bries Belgium Hasselt
Universitair Ziekenhuis Antwerpen Ann Van de Velde Belgium Edegem
CH La Source Madga Alexis France Orleans
Centre Hospitalier Bruno Anglaret France Valence
Institut Privé de Cancérologie David Assouline France Grenoble
CHRU Hopital Purpan Michel Attal France Toulouse cedex 9
CH Louis Pasteur Faress Husseini France Colmar cedex
*C*U* ( CHU Clemenceau ) Isabelle Azais France Poitiers cedex
Centre Hospitalier de la c?te basqueHèmatologie Anne Banos France Bayonne
Hopital Henri Mondor Karim Belhadj France Creteil
CHRU Hopital Bretonneau Lotfi Benboubker France Tours cedex
CH René Dubois Riad Benramdane France Cergy-Pontoise
Hopital Augustin Morvan Adrian Tempescul France Brest cedex
Hopital Antoine Béclère Francois Boue France Clamart
Centre hospitalier de RoanneOncologie Médicale Nadine Boullanger France Roanne
GH de Institut Catholique St Vincent Christian Rose France Lille
Institut Gustave Roussy Jean-Henri Bourhis France Villejuif
Hopital Cochin Didier Bouscary France Paris Cedex 14
CHRU Hopital du bocage Denis Caillot France Dijon
Hopital Avicenne Philippe Casassus France Bobigny Cedex
CHU ESTAING Benoit De Renzis France Clermont Ferrand
CH Argenteuil Victor Dupouy Philippe C Genet France Argenteuil
Hopital d’instruction des armées Percy Thierry De Revel France Clamart Cedex
Hopital Necker Richard Delarue France Paris
CHRU Hopital du bocage Mamoun Dib France Angers cedex 01
Hopital de Mercy Véronique Dorvaux France METZ cedex 3
Institut Bergonié Gabriel Etienne France Bordeaux
Hopital Emile Muller Jean-Claude Eisenmann France Mulhouse
CHRU-Hopital Claude Huriez Thierry Facon France Lille cedex
Hopital Saint Louis Jean-Paul Fermand France Paris
Polyclinique Bordeaux Nord Aquitaine Olivier Fitoussi France Bordeaux
Hopital de l'Archet 1 Jean-Gabriel Fuzibet France Nice cedex 3
CHU Hopital St-Antoine Laurent Garderet France Paris
Clinique Claude BernardOncologie Marie-Hélène Gaspard France Albi
Centre Léon Bérard Catherine Sebban France Lyon
CH Kamel Ghomari France Beauvais
Centre René Huguenin Sylvie Glaisner France Saint Cloud
CHRU Hopital Trousseau Isabelle Griffoul France Tours
CHRU Hopital sud Médecine Interne Olivier Decaux France Rennes cedex 02
CHRU - Hotel Dieu Philippe Moreau France Nantes
CHRU Hopital de Hautepierre Raoul Herbrecht France 1 Avenue Molière
CHRU Hopitaux de Brabois Cyrille Hulin France Vandoeuvre cedex
CH - Hopital Dupuytren Arnaud Jaccard France Limoges Cedex 1
CH P. Chubert Henry Jardel France Vannes cedex
Institut de Cancerologie de Loire Jérome Jaubert France St Priest en Jarez
CH Régis Kaphan France Cannes Cedex
Hopital R. Debré Anne Quinquenel France Reims cedex
CHRU Hopital de Pontchaillou Martine Escoffre Barbe France Rennes Cedex
Centre Hospitalier Kamel Laribi France Le Mans cedex
Hopital de l'Archet 1 Laurence Legros France Nice cedex 3
Centre Henri Becquerel Pascal Lenain France Rouen cedex
Hospital Sainte Blandine Elena Loppinet France Metz
CH Jacques Coeur Abdallah Maakaroun France Bouges
CHU Margaret Macro France Caen
Centre Hospitalier Départemental Hervé Maisonneuve France La Roche -Sur-Yon cedex 9
Kremlin Bicêtre Stephan Pavy France Le Kremlin bicetre CDX
CHRU - Hopital du Haut Lévêque Gérald Marit France Pessac
CHU Hopital Edouard Herriot Mauricette Michallet France Lyon cedex
Centre Hospitalier Yves Le Foll Olivier Allangba France St-Brieuc cedex 1
CHG Rodez Laurent Mosser France Rodez
Hopital de Fleyriat Hubert Orfeuvre France Bourg en Bresse cedex
Centre Hospitalier de la Region d'Annecy Frédérique Orsini Piocelle France Rodez
CHRU Brigitte Pegourie France Grenoble cedex 09
CH Sophie Rigaudeau France Le Chesnay cedex
Hopital Hotel Dieu Bernard Rio France Paris cedex 04
Centre Hospitalier El Yamani Abderrazik France Blois cedex
CHU Montpellier - H?pital Lapeyronie Jean-Francois Rossi France Montpellier Cedex 5
CHU Sud Bruno Royer France Amiens
CHU Reims - Hopital Maison Blanche Jean-Paul Eschard France Reims
CH - Sce Hématologie Marc Simon France Valenciennes
Institut Paoli-Calmettes Anne-Marie Stoppa France Marseille Cedex 9
Clinique Pont de chaume Oncologie et Radiothérapie Etienne Suc France Montauban cedex
Centre Antoine Lacassagne Oncologie médicale et Hématologie Antoine Thyss France Nice cedex 1
Centre Hospitalier Gilles Salles France Lyon
Centre Francois Baclesse Jean-Pierre Vilque France Caen cedex 5
Centre Hospitalier William Morey Laurent Voillat France Chalon/Saone cedex
Centre Jean Bernard Eric Voog France Le Mans
Centre Hospitalier Général Marc Wetterwald France Dunkerque
Hopital J MonodRhumato Nord Charles Zarnitsky France Le Havre
Medizinische Fakult?t der Universit?t Rostock Christian Junghanss Germany Rostock
Universitatsklinikum Essen- Ulrich Dührsen Germany Essen
Universitaetsklinikum Dusseldorf Klinik fuer Haematologie Roland Fenk Germany Dusseldorf
Universitatsklinikum Giessen Matthias Rummel Germany Giessen
Staedtische Kliniken Frankfurt am Main H?chst H Guenter Derigs Germany Frankfurt am Main
Askepios Klinik St. Georg Matthias Zeis Germany Hamburg
Zentrum F. Innere Medizin II Robert- Bosch-Krankenhaus GmBH Walter Erich Aulitzky Germany Stuttgart
Universitatsklinikum Jena Lars-Olof Mügge Germany Jena
Klinikum der Johann-Wolfgang-Goethe-Universtat Oliver G Ottmann Germany München
Medizinische Klinik III Klinikum der Universit?t München-Gro?hadern Helmut Ostermann Germany München
Poliklinik A Martin Kropff Germany Muenster
Universitatsklinikum schleswig-Holstein Frank Gieseler Germany Lübeck
Ernst-Moritz-Arndt-Universit?t Greifswald Gottfried Dolken Germany Greifswald
Medizinische Klinik und Poliklinik II Dietger Niederwieser Germany Leipzig
Medizinische Klinik - Abteilung II Katja Weisel Germany Tübingen
Klinik fur Innere Medizin III Christian Langer Germany Ulm
Medizinische Kinik und Poliklinik I Christoph Rollig Germany Dresden
Alexandra Hospital, University of Athens Meletios-Athansios Dimopoulos Greece Athens
Attiko Hospital of Athens Ioannis Devernoulas Greece Athens
Evangelismos Hospital of Athens Sosana Delimpassi Greece Athens
University of Athens Panagiotis Panagiotidis Greece Athens
Theagenio Anticancer Hospital of Thessaloniki Konstantinos Zervas Greece Thessaloniki
Mater Misercordiae Hospital Peter O Gorman Ireland Dublin
University Hospital Galway Michael O'Dwyer Ireland Galway
Adelaide and Meath Hospital Helen Enright Ireland Dublin
Policlinico S. Orsola Michele Cavo Italy Bologna
Policlinico San Matteo Universita Di Pavia Alessandro Corso Italy Pavia 2
Ematologia ed Immunologia, Azienda Ospedaliera Nicola Di Renzo Italy Lecce
Azienda Policlinico Umberto I, Università Roberto Foa Italy Rome
Unità Operativa di Oncoematologia, Ospedale di Matera Alberto Fragasso Italy Matera
Clinica Ematologica, A.O.U. San Martino di Genova Letizia Canepa Italy Genova
Istituto Europeo di Oncologia - IEO Giovanni Martinelli Italy Milano
Arcispedale Santa Maria Nuova Barbara Gamberi Italy Reggio Emilia
Casa di Cura Maurizio Musso Italy Palermo
Ospedale Molinette Mario Boccadoro Italy Torino
A.O. Universitaria Ospedale S.Chiara Dip.Oncologia, Div. Ematologia Mario Petrini Italy Pisa
Oncoematologia, Istituto Nazionale Tumori Fondazione G. Pascale Antonio Pinto Italy Napoli
Istituto Nazionale Tumori Regina Elena, Struttura Complessa Ematologia ed Unita di Cellule Staminali Francesco D Pisani Italy Roma
Presidio Ospedaliero A. Perrino Angela Melpignano Italy Milano
Policlinico di Modena Stefano Sacchi Italy Modena
Oncologia Medica, Università della Magna Grecia Pierfrancesco Tassone Italy Catanzaro
Ospedale Civile Antonio Lazzaro Italy Piacenza
U.O. di Ematologia e Trapianto di Midollo Osseo Fabio Ciceri Italy Milano
Auckland City Hospital Peter Browett New Zealand Auckland
Wellington Hospital Ken Romeril New Zealand Newtown
Christchurch Hospital Andrew Butler New Zealand Christchurch
Instituto Português de Oncologia de Lisboa Joana Perreira Portugal Lisboa
Instituto Português de Oncologia Porto Angelo Martins Portugal Porto
Hospital de Santa Maria Graca Esteves Portugal Lisboa
Hospitais da Universidade de Coimbra Catarina Geraldes Portugal Coimbra
Hospital de Sao Marcos Marques Herlander Portugal Braga
Hospital de Santo Antonio- Porto Cristina Goncalves Portugal Porto
Hospital 12 de Octubre Juan José Lahuerta-Palacios Spain Madrid
Hospital Son Llatzer Joan Bargay Lleonart Spain Palma de Mallorca
Hospital Clinico Santiago de Compostela Marta Sonia Gonzalez Perez Spain Santiago de Compostela
Hospital Universtario Marques de Valdecilla Arantxa Bermudez Spain Santander
Hospital General Universitario Morales Messeguer Felipe De Arriba de la Fuente Spain Murcia
Hospital Clinico San Carlos Marta Mateos-Morales Spain Madrid
Hospital Univ. Josep Trueta Yolanda Gonzales-Montes Spain Girona
Hospital Universitario La Paz Ana Lopez de la Guia Spain Madrid
Hospital Germans Trias i Pujol Albert Oriol Rocafigueira Spain Badalona (Barcelona)
Instituto Catalan de Oncologia-Hospital Duran Victoria Clapés Spain Barcelona
Clinica Universitaria de Navarra, Felipe Prosper-Cardoso Spain Pamplona
Hospital Clínico Virgen de la Victoria Gemma Ramírez Spain Málaga
Hospital Clínico Universitario de Valencia Anabel Teruel Casasus Spain Valencia
Hospital de la Santa Creu i Sant Pau Miguel Granell Spain Barcelona
Hospital Reina Sofia Antonio Torres Gómez Spain Cordoba
Hospital Sant Pau Josep Guma - Padro Spain Reus
Hosptial La Fe Javier De la Rubia Comos Spain Valencia
Hospital Miguel Servet Pilar Delgado Spain Zaragoza
Hospital de Donosti Asunción Echeveste - Gutierrez Spain Donostia
Hospital Clinico Universitario Lozano Blesa Luis Palomera-Bernal Spain Zaragoza
Karolinska University Hospital Huddinge Hareth Nahi Sweden Stockholm
Karolinska University HospitalSolna Astrid Gruber Sweden Stockholm
Linkoping University Hospital Lucia Ahlberg Sweden Linkoping
St. Gorans Hospital Fredrik Sjoo Sweden Stockholm
Centre Hospitalier Universitaire Vaudois (CHUV) Serge Leyvraz (former Dr. Ketterer) Switzerland Lausanne
Inselsspital Bern Thomas Pabst Switzerland Berne
UniversitatsSpital Basel Dominik Heim Switzerland Basel
Abteilung Onkologie/Haematologie des Kantonsspitals Aarau Mario Bargetzi Switzerland Aarau
Kantonsspital Münsterlingen Christian Taverna Switzerland Münsterlingen (TG)
Kantonsspital Graubunden Richard Cathomas Switzerland Chur
Kantonsspital Winterthur Daniel Binder Switzerland Winterthur
Dept of Haematology St Bartholomews Hospital Jamie Cavenagh United Kingdom London
Belfast City Hospital Haematology Department Mary Drake United Kingdom Belfast Northern Ireland
Royal Hallamshire Hospital Sheffield Teaching Hospitals NHS Trust Yousef Ezaydi United Kingdom Sheffield
Churchill Hospital Karthik Ramasamy United Kingdom Oxford
Royal United Hospital Christopher Knechtli United Kingdom Bath
The Beatson West of Scotland Centre Grant McQuaker United Kingdom Glasgow
University Hospital of Wales - Cardiff Christopher Fegan United Kingdom Cardiff
Royal Free Hospital Atul B Mehta United Kingdom London
Bristol Haematology and Oncology Centre Jenny Bird United Kingdom Bristol
Pinderfields General Hospital John Ashcroft United Kingdom West Yorkshire
Guy's and St Thomas' Hospital - London Majid Ali Kazmi United Kingdom London
Derriford Hospital Hannah Hunter United Kingdom Plymouth Crownhill Devon
Birminghman QE Mark Cook United Kingdom Birmingham West Midlands
Addenbrooke's Hospital Charles Crawley United Kingdom Cambridge
New Cross Hospital- Wolverhampton Supratik Basu United Kingdom Wolverhampton
Royal Bournemouth Hosp Rachel Hall United Kingdom Bournemouth Dorset
Gwynedd Hospital Jim Seale United Kingdom Bangor
Mayo Clinic Cancer Center Angela Dispenzieri USA MN Rochester
Fred Hutchinson Cancer Center William Bensinger USA WA Seattle
Stanford University Stanford Steven Coutre USA CA Stanford
Cedar Sinai Medical Center Dept of Medicine Robert Vescio USA CA Los Angeles
Hospital Maisonneuve - Rosemont Richard Leblanc Canada QC Montreal
Center for Cancer and Blood Disorders Victor Priego USA MD Bethesda
University of California, San Francisco- California Thomas G Martin USA CA San Francisco
Southern Illinois Hematology /Oncology James E Hays USA IL Centralia
Swedish Cancer Institute Henry Kaplan USA WA Seattle
University of Calgary Nizar Jacques Bahlis Canada AB Calgary
Hopital du Sacre-Coeur de Montreal Axel Tosikyan Canada QC Montreal
Cross Cancer Institute Andrew Belch Canada AB Edmonton
McGill University Chaim Shustik Canada QC Montreal
Leukemia/BMT Program of BCDiv of Hem, Vancouver Gen Hosp Kevin Song Canada BC Vancouver
Princess Margaret Hospital Christine Chen Canada ON Toronto
Kaiser Permanente Northwest Oncology/Hematology Negendra Tirumali USA OR Portland
Rush University Medical Center Stephanie A Gregory USA IL Chicago
Cancer Center of Kansas Shaker Dakhil USA KS Wichita
CHUM- Hopital Notre-Dame Bernard Lemieux Canada QC Montreal
London Health Science Centre Leonard Minuk Canada ON London
Burnaby Hospital Regional Cancer Center Wendy Lam Canada BC Burnaby
Dakota Cancer Institute Mahendra Gupta USA ND Fargo
Palm Beach Cancer Institute, LLC Robert Jacobson USA FL West Palm Beach
CHUQ - Hotel-Dieu de QuebecHematology - Oncology Marc Lalancette Canada QC Quebec
University of Texas Medical Branch Avi Markowitz USA TX Galveston
University of Pennsylvania Dan Vogl USA PA Philadelphia
Integrated Community Oncology Network Mehdi Moezi USA FL Orange Park
Odette Cancer Centre Matthew Cheung Canada ON Toronto
Queen Elizabeth II Health Sciences Center Darrell John White Canada NS Halifax
Royal Columbian Hospital Michael Noble Canada BC New Westminster
The Cancer Center Donald Gravenor USA TN Collierville
University of Tennessee Cancer Institute Furhan Yunus USA TN Memphis
Ottawa Hospital Richard Van der Jagt Canada ON Ottawa
Hospital Charles LeMoyne Pierre Desjardins Canada QC Greenfield Park
Baptist Cancer Institute Troy H Guthrie USA FL Jacksonville
Hotel-Dieu de Levis Felix Couture Canada QC Levis
University of AL Birmingham Diego De Idiaquez USA AL Birmingham
Hopital de la Cite-de-la-Sante Nathalie Aucoin Canada QC Laval
British Columbia Cancer Agency Gregory Dueck Canada BC Kelowna
Vancouver Island Cancer Center Jason Hart Canada BC Victoria
Cleveland Clinic Frederic Reu USA OH Cleveland
St. Luke's Hospital and Health Network Hikaru Nakajima USA PA Allentown
Saint John Regional Hospital Tony (Anthony James) Reiman Canada NB Saint John
Juravinski Cancer Centre Chrisostomos (Tom) Kouroukis Canada ON Hamilton
Sir Mortimer B. Davis - Jewish Genl Sarit Assouline Canada QC Montreal
BC Cancer Agency - Fraser Valley Centre Abdulwalhab Al-Tourah Canada BC Surrey
John H Stroger Hospital of Cook County Rose Catchatourian USA IL Chicago
University Hospitals of Cleveland Brenda Cooper USA OH Cleveland
Gabrail Cancer Center Nashat Gabrail USA OH Canton
Billings Clinic Jorge Nieva USA MT Billings
Ingalls Cancer Institute Mark Kozloff USA IL Harvey
Gainesville Heme Oncology Associates Manuel De la Puerta USA FL Gainesville
Orchard Healthcare Research, Inc. Stephanie Williams USA IL Chicago
Maine Center for Cancer Medicine/Blood Disorders Helen Ryan USA ME Scarborough
Gulf Coast Oncology Joseph Mace USA FL St. Petersburg
Arena Oncology Associates, PC Robert Weiner USA NY Lake Success
Gachon University Gil Hospital Jae Hoon Lee Korea South Incheon
Seoul National University Hospital Sung soo Yoon Korea South Seoul
National Cancer Center Hyeon Seok Eom Korea South Gyeonggi-do
Hwasun Chonnam National University Hospital Je-Jung Lee Korea South Hwasun-goon
Chungnam National University Hospital Deog-Yeon Jo Korea South Daejon
Chonbuk National University Hospital 42 Jae-Yong Kwak Korea South Jeonju
Daegu Catholic University Medical Center 3056-6 Hun-Mo Ryoo Korea South Daegu
Seoul National University Bundang Hospital Jeong-Ok Lee Korea South Seongnam
Severance Hospital Soo Jeong Kim Korea South Seongsanno
The Catholic University of Korea Seoul Chang Ki Min Korea South Seoul
Asan Medical Center Cheol won Suh Korea South Seoul
Samsung Medical Center Kihyun Kim Korea South Seoul
Inje University Busan Paik Hospital Won-Sik Lee Korea South Busan
Ewha Womans University Mokdong Hospital Yeung-Chul Mun Korea South Seoul
Hallym University Sacred Heart Hospital Hyo Jung Kim Korea South Anyang
National Taiwan University Hospital Shang-Yi Huang 中国 Tapei
Chang Gung Medical Foundation, Kaohsiung Memorial Hospital Lori Kam 中国 Niao-Sung Hsiang Kaohsiung County
China Medical University Hospital Su-Peng Yeh 中国 Taichung City
Veteran General Hospital - Taipei Tzeon-Jye Chiou 中国 Taipei
Chang Gung Medical Foundation, Linkou Memorial Hospital Ming-Chung Kuo 中国 Kuei Shan Taoyuan County
Metaxa Hospital Peiraias Panagiotis Repousis Greece Piraeus

伦理委员会信息

名称 审查结论 审查日期
首度医科大学附属北京朝阳医院医学伦理委员会 同意 2009-12-29
华西医院医学伦理委员会 修改后同意 2010-01-12
北京大学人民医院伦理委员会 修改后同意 2010-02-02
中国医学科学院血液病医院伦理委员会 同意 2010-02-26
瑞金医院药物临床试验伦理委员会 修改后同意 2010-03-30

试验状态信息

试验状态
进行中-招募完成
目标入组人数
国内: 26 人; 国际: 1590 人;
已入组例数
国内: 登记人暂未填写该信息; 国际: 登记人暂未填写该信息;
实际入组总例数
国内: 47 人 ; 国际: 1623 人;
第一例受试者签署知情同意书日期
国内:登记人暂未填写该信息;     国际:登记人暂未填写该信息;
第一例受试者入组日期
国内:2008-08-25;     国际:2008-08-25;
试验终止日期
国内:登记人暂未填写该信息;     国际:登记人暂未填写该信息;

临床试验结果摘要

版本号 版本日期

发布
问题